71 related articles for article (PubMed ID: 22410573)
21. The influence of the antithymocyte globulin dose on clinical outcomes of patients undergoing kidney retransplantation.
Linhares K; Taddeo JB; Cristelli MP; Proença H; Ficher KN; de Marco R; Gerbase-DeLima M; Medina-Pestana J; Tedesco-Silva H
PLoS One; 2021; 16(5):e0251384. PubMed ID: 33979389
[TBL] [Abstract][Full Text] [Related]
22. Natural Killer Cells in Post-Transplant Lymphoproliferative Disorders.
Nakid-Cordero C; Baron M; Guihot A; Vieillard V
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33921413
[TBL] [Abstract][Full Text] [Related]
23. Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017.
Sargen MR; Cahoon EK; Lynch CF; Tucker MA; Goldstein AM; Engels EA
JAMA Dermatol; 2020 Dec; 156(12):1307-1314. PubMed ID: 33146669
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Alemtuzumab and Anti-thymocyte Globulin Treatment for Acute Kidney Allograft Rejection.
van der Zwan M; Clahsen-Van Groningen MC; van den Hoogen MWF; Kho MML; Roodnat JI; Mauff KAL; Roelen DL; van Agteren M; Baan CC; Hesselink DA
Front Immunol; 2020; 11():1332. PubMed ID: 32719676
[TBL] [Abstract][Full Text] [Related]
25. Thymoglobulin vs. ATG-Fresenius as Induction Therapy in Kidney Transplantation: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.
Song T; Yin S; Li X; Jiang Y; Lin T
Front Immunol; 2020; 11():457. PubMed ID: 32318057
[No Abstract] [Full Text] [Related]
26. B cell reconstitution following alemtuzumab induction under a belatacept-based maintenance regimen.
Xu H; Mehta AK; Gao Q; Lee HJ; Ghali A; Guasch A; Kirk AD
Am J Transplant; 2020 Mar; 20(3):653-662. PubMed ID: 31596034
[TBL] [Abstract][Full Text] [Related]
27. Regulatory and Effector B Cells: A New Path Toward Biomarkers and Therapeutic Targets to Improve Transplant Outcomes?
Cherukuri A; Ding Q; Sharma A; Mohib K; Rothstein DM
Clin Lab Med; 2019 Mar; 39(1):15-29. PubMed ID: 30709503
[TBL] [Abstract][Full Text] [Related]
28. The Efficacy of Rabbit Anti-Thymocyte Globulin for Acute Kidney Transplant Rejection in Patients Using Calcineurin Inhibitor and Mycophenolate Mofetil-Based Immunosuppressive Therapy.
van der Zwan M; Clahsen-Van Groningen MC; Roodnat JI; Bouvy AP; Slachmuylders CL; Weimar W; Baan CC; Hesselink DA; Kho MML
Ann Transplant; 2018 Aug; 23():577-590. PubMed ID: 30115901
[TBL] [Abstract][Full Text] [Related]
29. Highly Diluted Acetylcholine Promotes Wound Repair in an
Uberti F; Morsanuto V; Ghirlanda S; Ruga S; Clemente N; Boieri C; Boldorini R; Molinari C
Adv Wound Care (New Rochelle); 2018 Apr; 7(4):121-133. PubMed ID: 29675337
[No Abstract] [Full Text] [Related]
30. Effect of Immunosuppression on Target Blood Immune Cells Within 1 Year After Lung Transplantation: Influence of Age on T Lymphocytes.
Coiffard B; Pelardy M; Loundou AD; Nicolino-Brunet C; Thomas PA; Papazian L; Dignat-George F; Reynaud-Gaubert M
Ann Transplant; 2018 Jan; 23():11-24. PubMed ID: 29302022
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory Conditions Dictate the Effect of Mesenchymal Stem or Stromal Cells on B Cell Function.
Luk F; Carreras-Planella L; Korevaar SS; de Witte SFH; Borràs FE; Betjes MGH; Baan CC; Hoogduijn MJ; Franquesa M
Front Immunol; 2017; 8():1042. PubMed ID: 28894451
[TBL] [Abstract][Full Text] [Related]
32. Rabbit anti-human thymocyte immunoglobulin for the rescue treatment of chronic antibody-mediated rejection after pediatric kidney transplantation.
Cihan Y; Kanzelmeyer N; Drube J; Kreuzer M; Lerch C; Hennies I; Froede K; Verboom M; Ahlenstiel-Grunow T; Pape L
Pediatr Nephrol; 2017 Nov; 32(11):2133-2142. PubMed ID: 28717935
[TBL] [Abstract][Full Text] [Related]
33. Dual Role of Natural Killer Cells on Graft Rejection and Control of Cytomegalovirus Infection in Renal Transplantation.
López-Botet M; Vilches C; Redondo-Pachón D; Muntasell A; Pupuleku A; Yélamos J; Pascual J; Crespo M
Front Immunol; 2017; 8():166. PubMed ID: 28261220
[TBL] [Abstract][Full Text] [Related]
34. A Comparison of Two Types of Rabbit Antithymocyte Globulin Induction Therapy in Immunological High-Risk Kidney Recipients: A Prospective Randomized Control Study.
Burkhalter F; Schaub S; Bucher C; Gürke L; Bachmann A; Hopfer H; Dickenmann M; Steiger J; Binet I
PLoS One; 2016; 11(11):e0165233. PubMed ID: 27855166
[TBL] [Abstract][Full Text] [Related]
35. A Proposal for Early Dosing Regimens in Heart Transplant Patients Receiving Thymoglobulin and Calcineurin Inhibition.
Barten MJ; Schulz U; Beiras-Fernandez A; Berchtold-Herz M; Boeken U; Garbade J; Hirt S; Richter M; Ruhpawar A; Schmitto JD; Schönrath F; Schramm R; Schweiger M; Wilhelm M; Zuckermann A
Transplant Direct; 2016 Jun; 2(6):e81. PubMed ID: 27500271
[TBL] [Abstract][Full Text] [Related]
36. Effects of anti-human T lymphocyte immune globulins in patients: new or old.
Wang DC; Wang X; Chen C
J Cell Mol Med; 2016 Sep; 20(9):1796-9. PubMed ID: 27084794
[TBL] [Abstract][Full Text] [Related]
37. Desensitization Strategies Pre- and Post-Cardiac Transplantation.
Cole RM; Kobashigawa JA
Curr Treat Options Cardiovasc Med; 2016 Feb; 18(2):8. PubMed ID: 26781656
[TBL] [Abstract][Full Text] [Related]
38. Immunomodulation with rabbit anti-thymocyte globulin in solid organ transplantation.
Ippoliti G; Lucioni M; Leonardi G; Paulli M
World J Transplant; 2015 Dec; 5(4):261-6. PubMed ID: 26722653
[TBL] [Abstract][Full Text] [Related]
39. The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients.
OʼLeary JG; Samaniego M; Barrio MC; Potena L; Zeevi A; Djamali A; Cozzi E
Transplantation; 2016 Jan; 100(1):39-53. PubMed ID: 26680372
[TBL] [Abstract][Full Text] [Related]
40. Induction by anti-thymocyte globulins in kidney transplantation: a review of the literature and current usage.
Malvezzi P; Jouve T; Rostaing L
J Nephropathol; 2015 Oct; 4(4):110-5. PubMed ID: 26457257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
